Regenerative Medical Technology Group Inc.
RMTG
$0.0531
$0.00316.20%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -27.91% | -9.70% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -27.91% | -9.70% | |||
| Cost of Revenue | -5.40% | -20.77% | |||
| Gross Profit | -37.94% | -3.70% | |||
| SG&A Expenses | -2.11% | 21.14% | |||
| Depreciation & Amortization | 5.79% | 286.33% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.91% | 9.00% | |||
| Operating Income | -255.63% | -64.75% | |||
| Income Before Tax | -71.82% | -19.08% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -71.82% | -19.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -71.82% | -19.08% | |||
| EBIT | -255.63% | -64.75% | |||
| EBITDA | -183.14% | -57.36% | |||
| EPS Basic | -71.78% | -19.06% | |||
| Normalized Basic EPS | -71.77% | -19.18% | |||
| EPS Diluted | -71.78% | -19.06% | |||
| Normalized Diluted EPS | -71.77% | -19.18% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||